The Price to Research Ratio, or PR Ratio, is used to value a company against the amount it spends on R&D. It is calculated as Market Capitalisation divided by R&D Expenditure. This is measured on a TTM basis and the uses diluted shares outstanding.
The Price to Research ratio is of most importance in research based businesses, such as pharmaceutical companies and can be useful for identifying research-led businesses that are investing significantly in development.
However, a large amount of spending on does not necessarily mean future profits are assured.
This is measured on a TTM basis and uses diluted shares outstanding.
| Ticker | Name | P / R | StockRank™ |
|---|---|---|---|
| LON:WEIR | Weir | -5,861.5 | 73 |
| LON:GCM | GCM Resources | -223.5 | 35 |
| LON:GETB | Getbusy | -20.8 | 45 |
| LON:INHC | Induction Healthcare | 1.1 | 28 |
| LON:SNG | Synairgen | 1.6 | 18 |